Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07505134 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Exploring the Influence of Glucagon-like Peptide -1 (GLP-1) Medications on Food Cravings, Food Selection, and Food Intake Following Exposure to Food Advertisements

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 3 months later Aug 2026 → Dec 2026
See other at-risk trials from Penn State University

Record History

  1. Notable Start date: May 2026 to Sep 2026 Primary completion pushed from Aug 2026 to Dec 2026 · Completion pushed from Sep 2026 to Dec 2026 · Eligibility criteria expanded, about 7 words · 2 more Show 5 more changesShow less
    • Primary completion pushed from Aug 2026 to Dec 2026
    • Completion pushed from Sep 2026 to Dec 2026
    • Eligibility criteria expanded, about 7 words
    • Secondary endpoints: details revised at 1 of 5 entries
    • Collaborators: details revised at 1 of 1 entry
  2. Minor Secondary endpoints: 4 to 5 Eligibility criteria expanded, about 4 wordsv2 Show 1 more changeShow less
    • Eligibility criteria expanded, about 4 words

    See this version in full on ClinicalTrials.gov ↗

  3. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this randomized control trial is to compare how food cravings, food selection, and food consumption change in response to frequent food advertisements compared to non-food advertisements in adults taking GLP-1 (weight loss) medications. The primary question we aim to answer is: do GLP-1 medications reduce an individual's vulnerability to external triggers that drive food cravings and consumption? Participants will: * report daily food consumption for a total of 10 days, * receive eight daily prompts to view food or non-food related advertisements, and respond to a short 9-question survey for 7 days, * answer several questionnaires, * and complete two in-person visits to complete a virtual reality food selection task.
Trial Details
NCT Number NCT07505134
Lead Sponsor Penn State University
Collaborators: Penn State Health
Conditions GLP - 1
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov